By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) Announces Inclusion Of VARUBI (Rolapitant) In NCCN Antiemesis Guidelines 9/24/2015 8:13:41 AM
Tesaro (TSRO) Appoints Martin Huber, M.D., As Senior Vice President And Chief Medical Officer 9/21/2015 10:28:53 AM
Tesaro (TSRO) Wins FDA Nod for Chemotherapy-Induced Nausea Drug Varubi 9/2/2015 6:24:23 AM
Tesaro (TSRO) Announces Participation At Three Investor Conferences 9/1/2015 10:26:13 AM
Tesaro, Inc. (TSRO) Announces Second-Quarter 2015 Operating Results 8/7/2015 8:22:10 AM
Tesaro, Inc. (TSRO) And Jiangsu Hengrui Medicine Co. Ltd. Announce Rolapitant License Agreement For China 7/30/2015 6:05:10 AM
Tesaro, Inc. (TSRO) To Announce Second-Quarter Financial Results On August 6, 2015 7/23/2015 2:04:48 PM
Tesaro, Inc. (TSRO) Appoints Grant C. Bogle As Senior Vice President And Chief Commercial Officer 7/13/2015 7:07:04 AM
Tesaro, Inc. (TSRO) Appoints Jeffrey H. Hanke, Ph.D., As Executive Vice President, Research & Development, And Chief Scientific Officer 6/29/2015 7:37:39 AM
Tesaro, Inc. (TSRO) Announces Successful Completion Of Rolapitant Bioequivalence Study 6/1/2015 10:48:39 AM